Ahold U.S.A., Inc.

Ahold U.S.A., Inc. produces a range of medical devices primarily focused on personal hygiene and minor wound care. These include unscented menstrual pads and tampons, dental floss, non-woven gauze pads, basic electric toothbrushes, and skin-cover adhesive strips—both antimicrobial and non-antimicrobial. Additionally, they manufacture autoinjector needles designed for use with prefilled pens, which are commonly used in diabetes management.

Ahold U.S.A., Inc. is based in the United States. Since the company operates within the U.S., its devices are subject to FDA regulations, including classification under FDA’s device categories (Class I, Class II, exempt (N), or unclassified (U)) and mandatory listing in the FDA’s Unique Device Identifier (UDI) database. This ensures compliance with U.S. medical device standards.

Ahold U.S.A., Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system helps track and identify medical devices throughout their distribution and use, ensuring transparency and traceability for regulatory and clinical purposes. This listing is required for devices classified under FDA regulations.

Ahold U.S.A., Inc.’s devices fall under FDA’s Class I and Class II classifications, which determine the regulatory controls applied to them. Class I devices generally pose minimal risk and may have fewer regulatory requirements, while Class II devices require stricter controls due to moderate risk. Some of their devices are classified as exempt (N) or unclassified (U), meaning they either have no specific regulatory requirements or are not yet assigned a formal class. Classification depends on factors like intended use and potential risk.